Rash Management : Episode 6

Interdisciplinary Approach to Managing Skin Toxicities

Video

Kathryn Ciccolini, RN, BSN, OCN, an oncology nurse at Memorial Sloan-Kettering Cancer Center (MSKCC), discusses the importance of an interdisciplinary team in the management of skin toxicities associated with anticancer therapies.

At MSKCC, there is a team dedicated to the management of skin toxicities associated with anticancer agents. This clinical and administrative team consists of a physician, two registered nurses, a patient care technician who is a trained medical photographer, and an excellent administrative team.

The success of this team is derived from being proactive with the management of dermatologic adverse events, Ciccolini says. The goal of the interdisciplinary team is to ensure that anticancer therapy does not need to be stopped, as a result dermatologic side effect.

In order for an interdisciplinary team to be successful, healthy, and high performing, it must continuously care about efficiency, productivity, trust, cohesion, and effective communication, believes Ciccolini. Moreover, the team should constantly strategize on ways to build, change, and improve for the future. Every member of the team is a critical piece toward patient care, adds Ciccolini.

Related Videos
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Ashish Saxena, MD, PhD
Scott Kopetz, MD, PhD, FACP
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
John M. Kirkwood, MD, Distinguished Service Professor of Medicine, Sandra and Thomas Usher Professor of Medicine, Dermatology & Translational Science, coleader, Melanoma and Skin Cancer Program, Division of Hematology/Oncology, the University of Pittsburgh
Daniel Olson, MD
Michael Leung, PharmD, an expert on colorectal cancer
A panel of 4 experts on colorectal cancer